發(fā)布時(shí)間：2018-05-21 11:15

  本文選題：門脈高壓 + 脾功能亢進(jìn)�。� 參考：《青海大學(xué)》2017年碩士論文

【摘要】：目的:探討TIPS聯(lián)合PSE對(duì)肝硬化門脈高壓合并脾亢患者門脈血流動(dòng)力學(xué)改變及機(jī)體免疫調(diào)節(jié)的影響。方法:所有入選66例病例,均通過(guò)入組標(biāo)準(zhǔn)及排除標(biāo)準(zhǔn)遴選,半隨機(jī)分為兩組,其中TIPS+PSE組36例,TIPS組30例。觀察指標(biāo)分別為術(shù)前、術(shù)后7d、30d患者門靜脈流速及直徑、分流道流速、外周血象、T細(xì)胞亞群、體液免疫功能指標(biāo)。結(jié)果:TIPS+PSE組與TIPS組比較:術(shù)后30d分流道流速、門脈主干流速、門脈主干直徑無(wú)統(tǒng)計(jì)學(xué)差異(P0.05);TIPS+PSE組與TIPS組血WBC比較:術(shù)后7d及術(shù)后30d具有統(tǒng)計(jì)學(xué)差異(P0.05),TIPS+PSE組,術(shù)后1d、7d、30d與術(shù)前比較具有統(tǒng)計(jì)學(xué)差異(P0.05);TIPS+PSE組與TIPS組PLT比較:術(shù)后7d及術(shù)后30d具有統(tǒng)計(jì)學(xué)差異(P0.05),TIPS+PSE組術(shù)后7d、30d與術(shù)前對(duì)照差異具有顯著性(P0.05)。TIPS+PSE組與TIPS組CD3、CD4、CD8、CD4/CD8比較:術(shù)后7d及術(shù)后30d具有統(tǒng)計(jì)學(xué)差異(P0.05),TIPS+PSE組CD3、CD4、CD8、CD4/CD8術(shù)后7d及術(shù)后30d與術(shù)前比較具有統(tǒng)計(jì)學(xué)差異(P0.05)。TIPS+PSE組與TIPS組IgA、IgM、IgG比較:術(shù)后30d具有統(tǒng)計(jì)學(xué)差異(P0.05),TIPS+PSE組IgA、IgM、IgG術(shù)后30d與術(shù)前1d比較具有統(tǒng)計(jì)學(xué)差異(P0.05)。TIPS+PSE組與TIPS組術(shù)后并發(fā)癥比較均無(wú)統(tǒng)計(jì)學(xué)差異(P0.05)。結(jié)論:TIPS聯(lián)合PSE治療肝硬化門脈高壓合并脾亢,創(chuàng)傷小,安全性高,改善了門靜脈血流,有效緩解患者脾功能亢進(jìn)癥狀、提高外周血白細(xì)胞及血小板水平、改善機(jī)體細(xì)胞及體液免疫功能。
[Abstract]:Objective: to investigate the effect of TIPS combined with PSE on portal hemodynamics and immune regulation in patients with cirrhosis and portal hypertension complicated with hypersplenism. Methods: all 66 cases were randomly divided into two groups, including 36 cases in TIPS PSE group and 30 cases in Tips group. The parameters were portal vein velocity and diameter, shunt velocity, peripheral blood T cell subsets and humoral immune function. Results compared with TIPS group, there was no significant difference in shunt velocity and portal trunk diameter between PSE group and TIPS group 30 days after operation. There was no significant difference in the diameter of portal trunk between PSE group and TIPS group. There was a significant difference in WBC between PSE group and TIPS group on the 7th day after operation and 30 day after operation. There was significant difference in PLT between the PSE group and the TIPS group on the 1st day and the 7th day after operation. There was a significant difference between the 7 days after operation and the 30 days after the operation. There was a significant difference between the PSE group and the TIPS group on the CD3 CD4CD _ 4 ~ (8) CD _ 4 / CD _ 8: 7 days after the operation, there was a significant difference between the three groups (P < 0.05) and the control group (P < 0.05). There was a significant difference between the PSE group and the TIPS group in terms of CD4 / CD _ 8: 7 days after the operation, there was a significant difference between the PSE group and the TIPS group. There was statistical difference between the 30 days after operation and the 30 days after operation. There was statistical difference between the three groups (P0.05TIPS PSE group) on the 7th day after the operation and the 30 days after the operation compared with the preoperative group. There was a statistical difference between the PSE group and the TIPS group on the 30th day after the operation. There was a statistical difference between the 30 days after the operation and the 1d before operation in the group of P0.05TIPS PSE. There was no significant difference in postoperative complications between the tips PSE group and the TIPS group. Conclusion the treatment of liver cirrhosis with portal hypertension with hypersplenism combined with PSE has little trauma and high safety. It can improve the portal vein blood flow, relieve the symptoms of hypersplenism, and increase the level of peripheral blood leukocytes and platelets. Improve cellular and humoral immune function.
【學(xué)位授予單位】：青海大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R575.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 Ruth Carey,R.D.,L.D.;TIPS FOR PARENTS :FOOD AND DRINK FOR YOUNG ATHLETES[J];中國(guó)運(yùn)動(dòng)醫(yī)學(xué)雜志;2000年04期

2 楊建勇;;經(jīng)頸靜脈肝內(nèi)門體靜脈分流術(shù)(TIPS)的回顧與展望[J];臨床急診雜志;2000年03期

3 張永宏 ,周力;肝硬變門脈高壓癥患者24例TIPS術(shù)后遠(yuǎn)期療效觀察[J];貴州醫(yī)藥;2002年02期

4 蔣明德;秦建平;;TIPS的臨床應(yīng)用再評(píng)價(jià)[J];世界華人消化雜志;2003年12期

5 徐克;鐘紅珊;;迎接TIPS發(fā)展的第二個(gè)春天[J];放射學(xué)實(shí)踐;2006年05期

6 Douglas M.Coldwell;;The role of TIPS in the management of portal hypertension:a new perspective[J];介入放射學(xué)雜志;2006年12期

7 湯偉;;常規(guī)DSA技術(shù)在TIPS中的應(yīng)用[J];現(xiàn)代醫(yī)藥衛(wèi)生;2009年16期

8 皇甫瑜;秦建平;戴立里;蔣明德;;TIPS并發(fā)癥的研究進(jìn)展[J];西南國(guó)防醫(yī)藥;2009年12期

9 原姍姍;韓國(guó)宏;柏明;何創(chuàng)業(yè);殷占新;王建宏;祁興順;楊志平;張偉;;TIPS治療肝硬化頑固性腹水的預(yù)后因素分析[J];臨床肝膽病雜志;2011年05期

10 陳家飛;李蓮;李榮軍;;3D旋轉(zhuǎn)DSA在TIPS中的臨床應(yīng)用[J];局解手術(shù)學(xué)雜志;2011年05期

相關(guān)會(huì)議論文 前10條

1 李昊;韓國(guó)宏;殷占新;劉杰;丁杰;吳開(kāi)春;樊代明;;經(jīng)頸內(nèi)靜脈肝內(nèi)門腔靜脈分流術(shù)(TIPS)治療肝癌合并門靜脈高壓癥的臨床研究[A];第九次全國(guó)消化系統(tǒng)疾病學(xué)術(shù)會(huì)議專題報(bào)告論文集[C];2009年

2 楊建勇;;經(jīng)頸靜脈肝內(nèi)門體靜脈分流術(shù)(TIPS)的回顧與展望[A];中華醫(yī)學(xué)會(huì)第一次全國(guó)介入醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2001年

3 楊建勇;向賢宏;;TIPS技術(shù)臨床應(yīng)用的新進(jìn)展[A];中華醫(yī)學(xué)會(huì)第十八次全國(guó)放射學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2011年

4 ;TIPS治療原發(fā)性肝癌合并門靜脈高壓[A];第六屆西部介入放射學(xué)術(shù)會(huì)議寧夏醫(yī)學(xué)會(huì)放射學(xué)分會(huì)第四屆年會(huì)介入放射學(xué)新技術(shù)繼續(xù)教育學(xué)習(xí)班論文匯編[C];2009年

5 徐克;鐘紅珊;;迎接TIPS發(fā)展的第二個(gè)春天[A];第二屆醫(yī)學(xué)影像山東論壇論文集[C];2005年

6 王茂強(qiáng);高育t，

本文編號(hào)：1918977